Pharos : Ligand Details - tazemetostat

You are using an outdated browser. Please upgrade your browser to improve your experience.

Tazemetostat is an inhibitor of the methyltransferase, EZH2, and some EZH2 gain-of-function mutations including Y646X and A687V. Tazemetostat also inhibited EZH1 with a half-maximal inhibitory concentration (IC50) of 392 nM, approximately 36 times higher than the IC50 for inhibition of EZH2

Ligand Summary

Ligand Structure

Rendered image for the query structure

Synonyms & Links

UNII: Q40W93WPE1

PubChem: 66558664

Guide to Pharmacology: 7011

ChEMBL: CHEMBL3414621

DrugCentral: 5380

LyCHI: ZKMT6LPDYPMY

Target Activities

Explore Associated and Predicted Targets

EZH2

Tclin

Histone-lysine N-methyltransferase EZH2

14 Activities

Items per page:

1 – 10 of 14

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	7.96			23620515

IC50	9.47		Bioorg Med Chem Lett, (2020) 30:5:126957	31959420

IC50	9		Bioorg. Med. Chem. Lett., (2015) 25:17:3644	26189078

IC50	9		Bioorg. Med. Chem. Lett., (2015) 25:17:3644	26189078

Ki	8.6		J. Med. Chem., (2015) 58:4:1596	25406853

IC50	8.5		None, (2015) None:None:None

IC50	7.96		None, (2015) None:None:None

IC50	7.96		None, (2016) None:None:None

IC50	7.89		None, (2015) None:None:None

IC50	7.89		None, (2015) None:None:None

EED

Tchem

Polycomb protein EED

3 Activities

Items per page:

1 – 3 of 3

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	8.7		J Med Chem, (2017) 60:6:2215	28092155

IC50	7.4		J Med Chem, (2017) 60:6:2215	28092155

IC50	8.7		https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3414621

EZH1

Tchem

Histone-lysine N-methyltransferase EZH1

1 Activities

Items per page:

1 – 1 of 1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	6.41	INHIBITOR	https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf